Back
Appili Therapeutics Vs. ESSA Pharma Industry Stock Comparison
Sell
29
APLIF
Appili Therapeutics
Last Price:
0.02
Seasonality Move:
-9.36%
Sell
27
EPIX
ESSA Pharma
Last Price:
1.73
Seasonality Move:
42.73%
Sell
29
Appili Therapeutics (APLIF)
is a Sell
Is Appili Therapeutics a Buy, Sell or Hold?
- The current Appili Therapeutics [APLIF] share price is $0.02. The Score for APLIF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- APLIF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ESSA Pharma (EPIX)
is a Sell
Is ESSA Pharma a Buy, Sell or Hold?
- The current ESSA Pharma [EPIX] share price is $1.72. The Score for EPIX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- EPIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLIF Stock Price Chart
What is Appili Therapeutics's stock price today?
-
The Appili Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLIF is experiencing selling pressure, which indicates risk of future bearish movement.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $1.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing selling pressure, which indicates risk of future bearish movement.
APLIF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 46.37 | Sell |
Chaikin Money Flow: | 118182 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.03 - 0.03) | Sell |
Bollinger Bands (100): | (0.03 - 0.03) | Sell |
EPIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.11 | Sell |
Relative Strength Index (14 RSI): | 23.15 | Sell |
Chaikin Money Flow: | -482582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.96 - 6) | Sell |
Bollinger Bands (100): | (3.8 - 6.48) | Sell |
APLIF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Sell |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.02 | Sell |
200-day SMA: | 0.03 | Sell |
8-day EMA: | 0.02 | Sell |
20-day EMA: | 0.03 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.03 | Sell |
EPIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.78 | Sell |
20-day SMA: | 3.45 | Sell |
50-day SMA: | 5.12 | Sell |
200-day SMA: | 6.33 | Sell |
8-day EMA: | 1.99 | Sell |
20-day EMA: | 3.07 | Sell |
50-day EMA: | 4.36 | Sell |
200-day EMA: | 5.46 | Sell |
Appili Therapeutics Earnings Growth & APLIF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ESSA Pharma Earnings Growth & EPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.22 per share.
Appili Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ESSA Pharma Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |